Highlights:
- South Korea will conduct a clinical trial by mixing COVID-19 vaccine doses developed by AstraZeneca, Pfizer, and BioNTech.
- Many countries are using different COVID-19 vaccines for their first and second doses due to delays in supplies.
- The trial will be conducted on 50 military personnel who were vaccinated with the first dose of AstraZeneca.
South Kor....
Tags : South Korea, vaccines, mix-n-match, AstraZeneca, Pfizer,
comments (0)